At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
PREFERS PREFERS (Preserved and Reduced Ejection Fraction Epidemiological Regional Study) Stockholm Heart Failure Study
In Brief
An observational study evaluating Cardiac imaging in the PREFERS and CABG PREFERS cohorts, Biomarker analysis in the PREFERS and CABG PREFERS chorts, and 1 other intervention for Heart Failure, Diastolic and Heart Failure,Congestive. Completed, enrolled 683 participants across 1 site.
Detailed Summary
Heart failure (HF) with preserved (HFpEF) or reduced (HFrEF) ejection fraction is associated with poor prognosis and quality of life. While the incidence of HFrEF is declining and HF treatment is effective, HFpEF is increasing, with no established therapy. PREFERS Stockholm is an epidemiological study with the aim of improving clinical care and research in HF and to find new targets for drug treatment in HFpEF starting with a cardiac biopsy study in elective CABG patiens.
Study Details
Timeline
Interventions
performed at baseline and after 1 year
blood samples will be taken for biomarker analysis at baseline and after 1 year
myocardial biopsies from the right trium the left and right ventricles will be taken during elective CABG